Finecure Pharmaceuticals invite strategic business partenerships in models of business as Branded Formulation Business, out-licencing, CMO, institutional and tender supply, domestic and overseas distribution, contract manufacturing and strategic licensing. These are backed by companys pool of talented Human Capital together with state of art manufacturing sites to manufacture Formulations in finished disage, driven with DSIR-recognised R&D centre
The brands are entrusted by 40,000+ practitioners and and are supplied across 20+ countries including key markets as North America, Latin America, South East Asia, Africa, WANA and domestic market
Become a Partner
Registration-ready dossiers and supply for partners worldwide — 20+ active markets including the United States, backed by 100+ international registrations.
Export Enquiry
Participation in government, Ministry of Health and institutional tenders, with the documentation set compiled to the requirements of the awarding authority.
Tender & Institutional Enquiry
Five dedicated blocks. Audit-ready capacity, from an established formula to full development and scale-up.
CDMO Enquiry
Out-licensing and P2P co-development from a ready-to-file dossier pipeline.
Licensing Enquiry
Dedicated, moisture-controlled supply of amoxicillin-clavulanate from a 100% isolated, sub-20% RH block.
Clavulanic P2P Enquiry
Ethical Rx brands prescribed by 40,000+ practitioners and stocked at 80,000+ pharmacies across India.
Trade Enquiry
A 100% physically isolated beta-lactam block with independent HVAC, holding relative humidity below 20% – the condition moisture-sensitive Amoxicillin + Clavulanate requires for commercial-scale stability across tablets, dispersible tablets, and dry syrups. A de-risked supply line for one of the world’s most in-demand antibiotic combinations.
A separate, dedicated, PIC/S-approved cephalosporin injectable plant – segregated under GMP as cephalosporin manufacture legally requires, and independent of the Clavulanic block. Aseptic liquid and dry-powder vials for critical-care and institutional sterile supply.
Finecure works with importers, distributors, institutions, and CDMO partners worldwide. Whatever the market or the molecule, the business development team responds with a defined supply and regulatory pathway.